TRACKS&Co SRL
The score of TRACKS&Co shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +58 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
TRACKS&Co's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 51,651 € | ||||
| Equity | 258,228 € | ||||
| Cash | 461,933 € | ||||
| EBITDA | 87,932 € | ||||
| Total assets | 528,835 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Jun 2026
- Year ended 31 Dec 2024filed on 21 Jul 2025
- Year ended 30 Jun 2023filed on 02 Jan 2024
- Year ended 30 Jun 2022filed on 21 Jan 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
TRACKS&Co's financial analysis
- Solvency48.8%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of TRACKS&Co
TRACKS&Co's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0837.109.802
- VAT number
- BE0837109802
- Peppol
- Registered · 0208:0837109802 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jun 2011
- Registered office
- 7050 Jurbise
- Latest accounts
- 2025 · filed on 21 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
TRACKS&Co (SRL) has been based in Jurbise since 2011, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 51,651 € and equity of 258,228 €; its revenue is not published. Its solvency stands at 48.8%, below the median of its sector (58.2%).
Companies similar to TRACKS&Co
Companies in the same business, of comparable size and area, outside its group.
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- PFx Biotech Research and experimental development on natural sciences and engineering Ghent · balance sheet 593,378 €
- MDTrials Research and experimental development on natural sciences and engineering Bruges · balance sheet 372,427 €
- Semaphar Research and experimental development on natural sciences and engineering Jodoigne · balance sheet 579,404 €
- NorthboundBio Research and experimental development on natural sciences and engineering Leuven · balance sheet 286,592 €
- Asylia Diagnostics Research and experimental development on natural sciences and engineering Leuven · balance sheet 552,090 €
- NasaPharm Research and experimental development on natural sciences and engineering Blegny · balance sheet 606,267 €
- Huisarts Nadine Costers Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 502,719 €
Frequently asked questions about TRACKS&Co
What is the revenue of TRACKS&Co?
TRACKS&Co files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of TRACKS&Co?
In Belgium, the VAT number is the company number prefixed with BE: BE0837109802 for TRACKS&Co, if the company is VAT-registered. Its company number (CBE) is 0837.109.802.
Where is the registered office of TRACKS&Co?
According to the CBE register, the registered office of TRACKS&Co is in 7050 Jurbise.
What is the equity of TRACKS&Co?
At the close of the 2025 financial year, the equity of TRACKS&Co amounts to 258,228 €, a solvency of 48.8% of total assets.
Who manages TRACKS&Co?
The register lists 1 active mandates at TRACKS&Co. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of TRACKS&Co
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →